BioLargo, Inc. Posts Investor Presentation and Webcast Transcript

What Happened BioLargo, Inc. (BLGO) filed a Form 8-K on September 14, 2026 under Item 7.01 to disclose materials presented at an investor webcast on September 10, 2026 at 1:00 PM Pacific Time. The company attached the slide deck as Exhibit 99.1 and the webcast transcript as Exhibit 99.2 and incorporated the slides by reference in the filing (Regulation FD disclosure).

Key Details

• Filing date: September 14, 2026 (Form 8-K, Item 7.01).
• Presentation date/time: September 10, 2026 at 1:00 PM PT (webcast investor conference).
• Exhibits included: 99.1 (slide deck) and 99.2 (webcast transcript).
• The filing is a Regulation FD disclosure — materials were made public via the 8-K.

Why It Matters This 8-K gives investors access to the company’s public investor presentation and the full webcast transcript, which may include updates on strategy, operations, product development, or near-term plans. The filing itself does not report earnings, executive changes, mergers, or financial statements — it simply makes the presentation materials publicly available under Regulation FD for equal access by all investors. Investors should review the attached slides and transcript for any material disclosures or forward-looking statements.